World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
38142
World Ranking
18245
National Ranking
1657

Keith G. Oldroyd publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Keith G. Oldroyd sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 362 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Keith G. Oldroyd D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Keith G. Oldroyd sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Keith G. Oldroyd is affiliated with the Golden Jubilee National Hospital in the United Kingdom. Their research primarily focuses on medicine, with a significant emphasis on cardiology and cardiovascular medicine.

They have published extensively in the subfields of cardiology and cardiovascular medicine, surgery, radiology, nuclear medicine and imaging, biomedical engineering, and emergency medicine. Their main topics of work include coronary interventions and diagnostics, cardiac imaging and diagnostics, acute myocardial infarction research, antiplatelet therapy and cardiovascular diseases, cardiovascular function and risk factors, cardiac arrest and resuscitation, and mechanical circulatory support devices.

Their recent papers cover important areas in cardiovascular medicine, including:

  • Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery, 2021, New England Journal of Medicine
  • Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction, 2021, JAMA Cardiology
  • Ticagrelor With or Without Aspirin After Complex PCI, 2020, Journal of the American College of Cardiology
  • Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS, 2020, European Heart Journal
  • Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR), 2021, European Heart Journal

Their frequent co-authors include:

  • Colin Berry (34 collaborative works)
  • Margaret McEntegart (25 collaborative works)
  • Hany Eteiba (20 collaborative works)
  • Peter McCartney (19 collaborative works)
  • Richard Good (19 collaborative works)

Keith G. Oldroyd's publications appear regularly in these venues:

  • Journal of the American College of Cardiology (16 publications)
  • JACC: Cardiovascular Interventions (13 publications)
  • European Heart Journal (8 publications)
  • EuroIntervention (6 publications)
  • Circulation Cardiovascular Interventions (5 publications)

Best Publications

  • Fractional flow reserve versus angiography for guiding percutaneous coronary intervention

    Bernard De Bruyne;Uwe Siebert;Fumiaki Ikeno;Volker Klauss

  • Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease

    Bernard De Bruyne;Bindu Kalesan;Emanuele Barbato;Zsolt Piroth

  • Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study

    Nico H.J. Pijls;William F. Fearon;Pim A.L. Tonino;Uwe Siebert;Uwe Siebert

  • Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation

    Pim A.L. Tonino;William F. Fearon;Bernard De Bruyne;Keith G. Oldroyd

  • Randomized trial of preventive angioplasty in myocardial infarction.

    David S. Wald;Joan K. Morris;Nicholas J. Wald;Alexander J. Chase

  • Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease

    Bernard De Bruyne;William F. Fearon;Nico H.J. Pijls;Emanuele Barbato

  • PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

    Holger Thiele;Ibrahim Akin;Marcus Sandri;Georg Fuernau

  • Ticagrelor with or without Aspirin in High-Risk Patients after PCI

    Roxana Mehran;Usman Baber;Samin K Sharma;David J Cohen

  • Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

    Timo Mäkikallio;Niels R Holm;Mitchell Lindsay;Mark S Spence

  • Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

    Philip Urban;Ian T Meredith;Alexandre Abizaid;Stuart J Pocock

  • Five-Year Outcomes with PCI Guided by Fractional Flow Reserve

    P. Xaplanteris;S. Fournier;N. H. J. Pijls;W. F. Fearon

  • Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    Pascal Vranckx;Marco Valgimigli;Peter Jüni;Christian Hamm

  • Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction

    Anthony H. Gershlick;Amanda Stephens-Lloyd;Sarah Hughes;Keith R. Abrams

  • Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic Patients: 1-Year Results of the CARDia (Coronary Artery Revascularization in Diabetes) Trial

    Akhil Kapur;Roger J. Hall;Roger J. Hall;Iqbal S. Malik;Ayesha C. Qureshi

  • Randomized Trial of Simple Versus Complex Drug-Eluting Stenting for Bifurcation Lesions. The British Bifurcation Coronary Study: Old, New, and Evolving Strategies

    David Hildick-Smith;Adam J. de Belder;Nina Cooter;Nicholas P. Curzen

  • Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial

    Lokien X van Nunen;Frederik M Zimmermann;Pim A L Tonino;Emanuele Barbato

  • Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial

    Thomas J. Ford;Bethany Stanley;Richard Good;Paul Rocchiccioli

  • Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

    Daniel J F M Thuijs;A Pieter Kappetein;Patrick W Serruys;Friedrich-Wilhelm Mohr

  • Smoke-free legislation and hospitalizations for acute coronary syndrome

    Jill Pell;Sally Haw;Stuart M Cobbe;David E Newby

  • Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention

    William F. Fearon;Adrian F. Low;Andy S. Yong;Ross McGeoch

Frequent Co-Authors

Colin Berry
Colin Berry University of Glasgow
Mark C. Petrie
Mark C. Petrie University of Glasgow
Ian Ford
Ian Ford University of Glasgow
Alex McConnachie
Alex McConnachie University of Glasgow
Naveed Sattar
Naveed Sattar University of Glasgow
Bernard De Bruyne
Bernard De Bruyne Cardiovascular Center Aalst
Paul Welsh
Paul Welsh University of Glasgow
Nico H.J. Pijls
Nico H.J. Pijls Eindhoven University of Technology
William F. Fearon
William F. Fearon Stanford University
John P. Greenwood
John P. Greenwood University of Leeds

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to a broad range of fulfilling pathways, many of which start with flexible online education options. If you're interested in preventive care and wellness, consider nutrition degrees online to gain specialized knowledge in dietetics and health promotion.

For those drawn to healthcare leadership, top cahme accredited mha programs offer advanced management skills essential for hospital and clinic administration roles.

Nursing professionals looking to upskill can find accelerated options via online rn to bsn no clinicals, a convenient way to broaden your practice and credentials without the need for extra clinical hours.

If your goal is to reach the highest levels of clinical practice, dnp programs online enable you to complete your Doctor of Nursing Practice efficiently and flexibly.

These online degrees not only offer convenience and accessibility, but also align with emerging healthcare demands—empowering you to advance your career without putting life on hold.

Best Scientists Citing Keith G. Oldroyd

Trending Scientists